<DOC>
	<DOCNO>NCT00203541</DOCNO>
	<brief_summary>The primary objective pivotal study determine new antimicrobial dressing , apply sternal incision cardiac surgical subject , demonstrate decrease cumulative incidence rate ( CI ) localize , superficial infection sternal incisional site compare control group , regular , non-antimicrobial dressing .</brief_summary>
	<brief_title>Effects New Antimicrobial Dressing Wound Healing Incidence Sternal Wound Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Wound Infection</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Sign inform consent form approve Institutional Review Board . Adults least 18 year age . Be undergoing cardiopulmonary bypass surgery median sternotomy . Be able return study site , need , sternal surgical incision site inspect . Be participate concurrently another clinical trial involve investigational drug device would interfere study . Be need leave ventricular assist device . Have active preoperative infectious process . Subject receive another topical antimicrobial agent ( i.e. , DermabondÂ® Topical Skin Adhesive ) study dress ( assign randomization schedule ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>